SCHEMBL851632

SCHEMBL851632

C[C@@](Cc1ccccc1)(N=O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.50
HIF1A Q16665 1/20 0.50
LMNA P02545 1/20 0.47
CYP2D6 P10635 1/20 0.47
SLC6A2 P23975 1/20 0.45
TAAR1 Q96RJ0 1/20 0.45
FDPS P14324 1/20 0.44
MMP8 P22894 4/20 0.44
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
CYP3A4 P08684 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
TRPA1 O75762 1/20 0.42
RECQL P46063 2/20 0.41
CYP1A2 P05177 2/20 0.41
BLM P54132 1/20 0.41
MAPK1 P28482 1/20 0.41
CES2 O00748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28530804 0.87 LMNA (0.46) SMN1; SMN2HIF1ALMNACYP2D6SLC6A2
SCHEMBL8014762 0.86 SMN1; SMN2 (0.52) SMN1; SMN2HIF1ALMNACYP2D6SLC6A2
SCHEMBL503691 0.86 SMN1; SMN2 (0.52) SMN1; SMN2HIF1ALMNACYP2D6SLC6A2
SCHEMBL3694695 0.81 BLM (0.39) SMN1; SMN2HIF1ALMNACYP2D6FDPS
SCHEMBL135997 0.80 SMN1; SMN2 (0.46) SMN1; SMN2HIF1ALMNACYP2D6SLC6A2
SCHEMBL669497 0.80 SMN1; SMN2 (0.46) SMN1; SMN2HIF1ALMNACYP2D6SLC6A2
SCHEMBL27908890 0.79 SMN1; SMN2 (0.57) SMN1; SMN2HIF1ALMNACYP2D6SLC6A2
SCHEMBL3270060 0.76 SMN1; SMN2 (0.53) SMN1; SMN2HIF1ALMNACYP2D6SLC6A2
SCHEMBL8710382 0.75 SMN1; SMN2 (0.57) SMN1; SMN2HIF1ALMNACYP2D6SLC6A2
SCHEMBL517462 0.75 SMN1; SMN2 (0.57) SMN1; SMN2HIF1ALMNACYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3086779-A2 SUSTAINED RELEASE DEPOT FORMULATIONS OF THERAPEUTIC PROTEINS, AND USES THEREOF Kineta One, LLC (US) 2016-11-02 EP disclosed
EP-3024472-A2 OPHTHALMIC USES OF TOXIN-BASED THERAPEUTIC PEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF Kineta One, LLC (US) 2016-06-01 EP disclosed
WO-2015100370-A2 SUSTAINED RELEASE DEPOT FORMULATIONS OF THERAPEUTIC PROTEINS, AND USES THEREOF KINETA ONE, LLC (US) 2015-07-02 WO disclosed
WO-2015013330-A2 OPHTHALMIC USES OF TOXIN-BASED THERAPEUTIC PEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF KINETA ONE, LLC (US) 2015-01-29 WO disclosed
EP-2432488-A2 SELECTIVE AND POTENT PEPTIDE INHIBITORS OF KV1.3 Amgen, Inc (US) 2012-03-28 EP disclosed
WO-2010108154-A2 SELECTIVE AND POTENT PEPTIDE INHIBITORS OF KV1.3 AMGEN INC. (US) 2010-09-23 WO disclosed
EP-1796709-A2 ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1.3 POTASSIUM CHANNELS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-06-20 EP disclosed
WO-2006042151-A2 ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1.3 POTASSIUM CHANNELS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-04-20 WO disclosed